CN Patent

CN115671074B — 一种甲磺酸仑伐替尼制剂及其制备方法

Assigned to Zhengzhou Antu Industrial Group Co ltd · Expires 2024-06-04 · 2y expired

What this patent protects

本发明公开了一种甲磺酸仑伐替尼制剂及其制备方法,属于药物制剂技术领域。本发明所述的甲磺酸仑伐替尼制剂,包括以下成分:甲磺酸仑伐替尼、碳酸钙、甘露醇、低取代羟丙基纤维素、羟丙基纤维素、微晶纤维素和滑石粉。所述甲磺酸仑伐替尼中C晶型占15wt%~30wt%,其余为无定型。本发明通过控制制剂中甲磺酸仑伐替尼中C晶型的含量,使得所述制剂具有最佳的溶出效果,批间质量差异也更小,同时对原料药甲磺酸仑伐替尼粒径的要求更低,当甲磺酸仑伐替尼的粒径为D90≤40μm时即可获得粒度分布均匀、装量差异小、溶出效果佳的甲磺酸仑伐替尼制剂。

USPTO Abstract

本发明公开了一种甲磺酸仑伐替尼制剂及其制备方法,属于药物制剂技术领域。本发明所述的甲磺酸仑伐替尼制剂,包括以下成分:甲磺酸仑伐替尼、碳酸钙、甘露醇、低取代羟丙基纤维素、羟丙基纤维素、微晶纤维素和滑石粉。所述甲磺酸仑伐替尼中C晶型占15wt%~30wt%,其余为无定型。本发明通过控制制剂中甲磺酸仑伐替尼中C晶型的含量,使得所述制剂具有最佳的溶出效果,批间质量差异也更小,同时对原料药甲磺酸仑伐替尼粒径的要求更低,当甲磺酸仑伐替尼的粒径为D90≤40μm时即可获得粒度分布均匀、装量差异小、溶出效果佳的甲磺酸仑伐替尼制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN115671074B
Jurisdiction
CN
Classification
Expires
2024-06-04
Drug substance claim
No
Drug product claim
No
Assignee
Zhengzhou Antu Industrial Group Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.